103 related articles for article (PubMed ID: 16969898)
1. [Osteoporosis risk factors among patients with schizophrenia].
Wyszogrodzka-Kucharska A; Rabe-Jabłońska J
Przegl Lek; 2006; 63(3):134-8. PubMed ID: 16969898
[TBL] [Abstract][Full Text] [Related]
2. [Decrease in mineral bone density in schizophrenic patients treated with 2nd generation antipsychotics].
Wyszogrodzka-Kucharska A; Rabe-Jabłońska J
Psychiatr Pol; 2005; 39(6):1173-84. PubMed ID: 16526183
[TBL] [Abstract][Full Text] [Related]
3. Osteoporosis in patients with schizophrenia.
Hummer M; Malik P; Gasser RW; Hofer A; Kemmler G; Moncayo Naveda RC; Rettenbacher MA; Fleischhacker WW
Am J Psychiatry; 2005 Jan; 162(1):162-7. PubMed ID: 15625215
[TBL] [Abstract][Full Text] [Related]
4. Relationship between antipsychotic medication, serum prolactin levels and osteoporosis/osteoporotic fractures in patients with schizophrenia: a critical literature review.
De Hert M; Detraux J; Stubbs B
Expert Opin Drug Saf; 2016 Jun; 15(6):809-23. PubMed ID: 26986209
[TBL] [Abstract][Full Text] [Related]
5. Osteoporosis and fracture risk in people with schizophrenia.
Kishimoto T; De Hert M; Carlson HE; Manu P; Correll CU
Curr Opin Psychiatry; 2012 Sep; 25(5):415-29. PubMed ID: 22744405
[TBL] [Abstract][Full Text] [Related]
6. Osteoporosis, schizophrenia and antipsychotics: the need for a comprehensive multifactorial evaluation.
Halbreich U
CNS Drugs; 2007; 21(8):641-57. PubMed ID: 17630817
[TBL] [Abstract][Full Text] [Related]
7. Bone mineral density in male schizophrenia patients: a review.
Meyer JM; Lehman D
Ann Clin Psychiatry; 2006; 18(1):43-8. PubMed ID: 16517452
[TBL] [Abstract][Full Text] [Related]
8. Reduced bone mineral density in patients with schizophrenia receiving prolactin raising anti-psychotic medication.
Meaney AM; O'Keane V
J Psychopharmacol; 2003 Dec; 17(4):455-8. PubMed ID: 14870961
[TBL] [Abstract][Full Text] [Related]
9. Osteopenia associated with increased prolactin and aging in psychiatric patients treated with prolactin-elevating antipsychotics.
Liu-Seifert H; Kinon BJ; Ahl J; Lamberson S
Ann N Y Acad Sci; 2004 Dec; 1032():297-8. PubMed ID: 15677434
[TBL] [Abstract][Full Text] [Related]
10. Antipsychotic-induced hyperprolactinaemia in patients with schizophrenia: considerations in relation to bone mineral density.
Stubbs B
J Psychiatr Ment Health Nurs; 2009 Nov; 16(9):838-42. PubMed ID: 19824978
[TBL] [Abstract][Full Text] [Related]
11. Gender-specific risk factors for low bone mineral density in patients taking antipsychotics for psychosis.
Jhon M; Yoo T; Lee JY; Kim SY; Kim JM; Shin IS; Williams L; Berk M; Yoon JS; Kim SW
Hum Psychopharmacol; 2018 Jan; 33(1):. PubMed ID: 29315805
[TBL] [Abstract][Full Text] [Related]
12. Accelerated osteoporosis in psychiatric patients: possible pathophysiological processes.
Halbreich U; Palter S
Schizophr Bull; 1996; 22(3):447-54. PubMed ID: 8873295
[TBL] [Abstract][Full Text] [Related]
13. Hyperprolactinemia and bone mineral density: the potential impact of antipsychotic agents.
Naidoo U; Goff DC; Klibanski A
Psychoneuroendocrinology; 2003 Apr; 28 Suppl 2():97-108. PubMed ID: 12650684
[TBL] [Abstract][Full Text] [Related]
14. Bone mineral density changes over a year in young females with schizophrenia: relationship to medication and endocrine variables.
Meaney AM; O'Keane V
Schizophr Res; 2007 Jul; 93(1-3):136-43. PubMed ID: 17467954
[TBL] [Abstract][Full Text] [Related]
15. A meta-analysis of prevalence estimates and moderators of low bone mass in people with schizophrenia.
Stubbs B; De Hert M; Sepehry AA; Correll CU; Mitchell AJ; Soundy A; Detraux J; Vancampfort D
Acta Psychiatr Scand; 2014 Dec; 130(6):470-86. PubMed ID: 25041606
[TBL] [Abstract][Full Text] [Related]
16. Antipsychotic-induced hyperprolactinaemia, hypogonadism and osteoporosis in the treatment of schizophrenia.
O'Keane V
J Psychopharmacol; 2008 Mar; 22(2 Suppl):70-5. PubMed ID: 18477623
[TBL] [Abstract][Full Text] [Related]
17. Skeletal morbidity in inflammatory bowel disease.
van Hogezand RA; Hamdy NA
Scand J Gastroenterol Suppl; 2006; (243):59-64. PubMed ID: 16782623
[TBL] [Abstract][Full Text] [Related]
18. Is antipsychotic treatment linked to low bone mineral density and osteoporosis? A review of the evidence and the clinical implications.
Crews MP; Howes OD
Hum Psychopharmacol; 2012 Jan; 27(1):15-23. PubMed ID: 22228316
[TBL] [Abstract][Full Text] [Related]
19. Bone Mineral Density in Schizophrenia: An Update of Current Meta-Analysis and Literature Review Under Guideline of PRISMA.
Tseng PT; Chen YW; Yeh PY; Tu KY; Cheng YS; Wu CK
Medicine (Baltimore); 2015 Nov; 94(47):e1967. PubMed ID: 26632691
[TBL] [Abstract][Full Text] [Related]
20. High bone turnover but normal bone mineral density in women suffering from schizophrenia.
Bergemann N; Parzer P; Mundt C; Auler B
Psychol Med; 2008 Aug; 38(8):1195-201. PubMed ID: 18366816
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
